Clin2
NCT07211724Worth exploringNot yet recruiting

Support for quitting meth in heart failure

Heart FailureMethamphetamine Use Disorder

Part of Heart & circulation clinical trials.

This study provides extra support to help people with heart failure who use methamphetamine to quit. The goal is to see if this support helps improve their heart health and overall well-being.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
50 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have heart failure and your heart's pumping ability is at or below 40% (your doctor can tell you).
  • You are 18 or older.
  • You currently use methamphetamine and want to quit.
  • You are a patient at LA General Medical Center or another DHS clinic.
  • You do not use other drugs besides meth (tobacco and marijuana are okay).
  • You do not have a history of alcohol abuse or alcoholism (social drinking is okay).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06461962Recruiting
Peer support for meth-related heart screening

This study tests whether a peer support program can help people who use methamphetamine get screened for early heart damage. It aims to connect you with care if screening shows possible heart strain.

Portland, Oregon
NCT07226596Recruiting
Methamphetamine use: can you reduce without quitting?

This study tests whether people who use methamphetamine can reduce use even if they are not completely abstinent. It offers a 12-week program and checks how you're doing for another 12 weeks after.

Lexington, Kentucky
NCT07086014Recruiting
Brain response to methamphetamine cues in men

This study uses brain scans to see how men with methamphetamine use disorder react to images or reminders of the drug. It aims to understand cravings and brain activity, which could help improve treatments.

New York, New York
NCT06899594Recruiting· Early Phase 1
Psilocybin for quitting methamphetamine

This trial tests whether psilocybin (a psychedelic medicine) can help people quit methamphetamine. You'll receive counseling before, during, and after the drug session, and your progress will be followed for several months.

Shreveport, Louisiana
NCT06788587Recruiting· Phase 2
Long-term stimulant for methamphetamine recovery

This study tests whether a high dose of a stimulant medication (lisdexamfetamine, an ADHD medicine) taken over many weeks can help people who have already completed a methamphetamine treatment program to stay off meth, reduce use, or avoid relapse.

Montreal, Quebec
NCT06989853Recruiting· Early Phase 1
Testing troriluzole for methamphetamine use disorder

This study tests whether a medication called troriluzole can help people who use methamphetamine. If you have methamphetamine use disorder and are not seeking treatment right now, this study may be an option for you.

Lexington, Kentucky

Hear when a new Heart failure trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.